HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Etiévant Selected Research

tafluposide

12/2000Preclinical antitumour activity of F 11782, a novel dual catalytic inhibitor of topoisomerases.
11/2000Characterization of the biological and biochemical activities of F 11782 and the bisdioxopiperazines, ICRF-187 and ICRF-193, two types of topoisomerase II catalytic inhibitors with distinctive mechanisms of action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Etiévant Research Topics

Disease

2Experimental Melanoma
12/2000 - 11/2000
1Carcinoma (Carcinomatosis)
07/2001
1Melanoma (Melanoma, Malignant)
12/2000
1Leukemia P388
11/2000
1Teratoma (Teratoid Tumor)
11/2000
1Neoplasms (Cancer)
03/2000

Drug/Important Bio-Agent (IBA)

2Pharmaceutical PreparationsIBA
07/2001 - 03/2000
2tafluposideIBA
12/2000 - 11/2000
1Etoposide (VP 16)FDA LinkGeneric
12/2000
1Dexrazoxane (Zinecard)FDA LinkGeneric
11/2000
14,4'- (1,2- dimethyl- 1,2- ethanediyl)bis- 2,6- piperazinedioneIBA
11/2000
1Proteins (Proteins, Gene)FDA Link
03/2000
1Multidrug Resistance-Associated ProteinsIBA
03/2000
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
03/2000
1multidrug resistance-associated protein 1IBA
03/2000